Efficacy of Guselkumab versus Ustekinumab in Stricturing Crohn's Disease: A Multicenter, Prospective, Observational Cohort Study (ChiCTR) - Sep 16, 2026 - P=N/A | N=346 | Recruiting | Sponsor: The second affiliated hospital of Zhejiang University school of medicine; The second affiliated hospital of Zhejiang University school of medicine
New trial • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease
|